Literature DB >> 15053445

Outcome after 40 years with rheumatoid arthritis: a prospective study of function, disease activity, and mortality.

Nicola J Minaur1, Richard K Jacoby, John A Cosh, Gordon Taylor, Johannes J Rasker.   

Abstract

In an inception cohort of 100 patients with rheumatoid arthritis (RA) we studied course and outcome after 40 years, regarding function, disease activity, cause and age of death, and prognostic factors. Function, joint count, erythrocyte sedimentation rate (ESR), hemoglobin (Hb), rheumatoid factor (RF), and the number of orthopedic operations were measured in 100 consecutive referrals between 1957 and 1963 with either definite or classical RA at one year after onset of symptoms. Subjects have been followed for a mean of 40 years, or until death. In May 1999, 84 subjects had died. Of the 16 survivors, 8 (50%) were severely disabled from RA while 5 (31%) had normal function. The mean joint score had gradually increased over 40 years. Death was directly attributable to RA in 13, while RA or its treatment contributed to death in 11 subjects. In the other 60 deceased subjects, cardiovascular causes accounted for 28 deaths (33% of total deaths). Features at one year that were associated with mortality up to 40 years after onset by regression analysis were: older age (p < 0.0001), lower Hb (p = 0.0461), and worse function (p < 0.0001). The standardized mortality ratio of the cohort at 40 years was 2.13 (confidence interval 1.26-3.60), and median survival was reduced by 10 years for men and 11 years for women compared to the general population. In conclusion, RA is a progressive disease impairing function up to 40 years after onset, with shortened life span. The leading cause of death was cardiovascular disease.

Entities:  

Mesh:

Year:  2004        PMID: 15053445

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  29 in total

1.  Severity of rheumatoid arthritis: the SEVERA study.

Authors:  Rafic Baddoura; Souha Haddad; Hassane Awada; Abdel Fattah Al-Masri; Georges Merheb; Said Attoui; Jad Okais; Jamil Messayke; Fadi Ghandour
Journal:  Clin Rheumatol       Date:  2005-12-15       Impact factor: 2.980

2.  Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.

Authors:  Tim Bongartz; Carlotta Nannini; Yimy F Medina-Velasquez; Sara J Achenbach; Cynthia S Crowson; Jay H Ryu; Robert Vassallo; Sherine E Gabriel; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2010-06

Review 3.  Prevention of Stroke in Rheumatoid Arthritis.

Authors:  Alicia M Zha; Mario Di Napoli; Réza Behrouz
Journal:  Curr Neurol Neurosci Rep       Date:  2015-12       Impact factor: 5.081

Review 4.  Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology.

Authors:  Emily K Wu; Robert D Ambrosini; R Matthew Kottmann; Christopher T Ritchlin; Edward M Schwarz; Homaira Rahimi
Journal:  Curr Rheumatol Rev       Date:  2019

5.  Iron status during anti-TNF therapy in children with juvenile idiopathic arthritis.

Authors:  Kristiina Aalto; Visa Honkanen; Pekka Lahdenne
Journal:  Clin Rheumatol       Date:  2010-09-30       Impact factor: 2.980

Review 6.  Intra-thoracic rheumatoid arthritis: Imaging spectrum of typical findings and treatment related complications.

Authors:  Thanissara Chansakul; Paul F Dellaripa; Tracy J Doyle; Rachna Madan
Journal:  Eur J Radiol       Date:  2015-07-17       Impact factor: 3.528

7.  Feelings of guilt and shame in patients with rheumatoid arthritis.

Authors:  Peter M Ten Klooster; Lieke C A Christenhusz; Erik Taal; Frank Eggelmeijer; Jan-Maarten van Woerkom; Johannes J Rasker
Journal:  Clin Rheumatol       Date:  2014-02-09       Impact factor: 2.980

Review 8.  A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease.

Authors:  Tracy J Doyle; Joyce S Lee; Paul F Dellaripa; James A Lederer; Eric L Matteson; Aryeh Fischer; Dana P Ascherman; Marilyn K Glassberg; Jay H Ryu; Sonye K Danoff; Kevin K Brown; Harold R Collard; Ivan O Rosas
Journal:  Chest       Date:  2014-03-01       Impact factor: 9.410

9.  Rheumatoid lung disease.

Authors:  Kevin K Brown
Journal:  Proc Am Thorac Soc       Date:  2007-08-15

Review 10.  Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs.

Authors:  Tuulikki Sokka; Minja Envalds; Theodore Pincus
Journal:  Mod Rheumatol       Date:  2008-04-25       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.